Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30022223HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30022224HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30022225HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30022226HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS20003385HPVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS20047165HPVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS20037865HPVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS20043928HPVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS44014774HTLV-1ENSG00000198793.14protein_codingMTORYesNo2475P42345
TCGA Plot Options
Drug Information
GeneMTOR
DrugBank IDDB12843
Drug NameOleandrin
Target IDBE0002386
UniProt IDP42345
Regulation Typedownregulator
PubMed IDs32452588
CitationsRoth MT, Cardin DB, Borazanci EH, Steinbach M, Picozzi VJ, Rosemury A, Wadlow RC, Newman RA, Berlin J: A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV Metastatic Pancreatic Adenocarcinoma. Oncologist. 2020 Oct;25(10):e1446-e1450. doi: 10.1634/theoncologist.2020-0440. Epub 2020 Jul 2.
GroupsExperimental; Investigational
Direct ClassificationCardenolide glycosides and derivatives
SMILESCO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H]([C@H](C[C@]43O)OC(C)=O)C3=CC(=O)OC3)C2)O[C@@H](C)[C@@H]1O
Pathways
PharmGKB
ChEMBLCHEMBL1075789